The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients. (2022). Jurnal Respirologi Indonesia, 42(4), 277–281. https://doi.org/10.36497/jri.v42i4.370